PharmaBoardroom

Interview with Teruo Yasufuku, Managing Director, Astellas Pharma…

When Astellas announced to expand its presence in India in 2009, you were already speaking of the company’s long commitment and solid…

Interview with Han Brouwer, General Manager, Actelion…

Founded in 1997 Actelion is certainly the “new kid on the block” when compared to some of the much older mainstays in the pharmaceutical industry.…

Interview with Gerben Klein Nulent, Chariman of the Management…

The group has significantly invested in Poland. Are you today generally satisfied with the initial and follow up investments from Mediq in the…

Interview with Bernhard Sixt, President & CEO, Agendia

Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities…

Interview with Rogerio MANSUR, Director of Operations, DHL Life…

Rogerio, you were one of the people responsible for integrating two well-established companies in the Brazilian market with the acquisition of Exel by…

Interview with Andrew Giddy, CEO, Nucleus Network

Please introduce Nucleus Network and the role it plays in the Australian pharmaceutical sector. Nucleus Network is an early-phase clinical research…

Interview with Rosa Maria Scavarelli, President, Theraskin Brazil

When we met you in 2007, as the head of the former Igefarma, the company was undergoing a transition – from branded generics into dermocosmetics…

Interview with Mark Brown, Head of Tahiland/Vietnam Cluster,…

You are General Manager for Thailand and Vietnam; two markets that certainly interest companies but at a very different stage of development. What are…

Interview with Norbert Oppitz, Senior Vice President Latin…

Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this…

Interview with George Varkanis, Managing Director, Celgene

As a biopharmaceutical company, how have the PBS reforms affected Celgene? Celgene looks at the PBS reforms more positively than negatively. As a…

Interview with Di Ford, Executive Director, Generic Medicines…

To begin, would you please introduce GMIA to Pharmaceutical Executive readers? The GMIA is an industry organization. Its six members are:…

Interview with Mark Glover , Vice President and Managing…

How have PBS reforms impacted Allergan in Australia? The PBS is a very good system that provides Australians with equity of access and has worked well…

Tagged with